Product Introduction:
Liftaz 1000/125 mg Injection is composed of Ceftriaxone (1000 mg) and Tazobactam (125 mg). Ceftriaxone is a broad-spectrum cephalosporin antibiotic, and Tazobactam is a beta-lactamase inhibitor that prevents bacterial resistance. This combination is especially effective in treating serious bacterial infections that are resistant to standard antibiotics.
Uses:
-
Severe respiratory tract infections
-
Urinary tract infections
-
Intra-abdominal infections
-
Skin and soft tissue infections
-
Bone and joint infections
-
Bacterial septicemia and post-operative infections
Benefits:
-
Broad-spectrum antibacterial activity
-
Effective in resistant and mixed bacterial infections
-
Suitable for critical care and hospital settings
-
Reduces the risk of treatment failure in severe infections
Composition (per vial):
-
Ceftriaxone 1000 mg
-
Tazobactam 125 mg
Side Effects:
-
Local pain/swelling at injection site
-
Diarrhea
-
Nausea or vomiting
-
Skin rash or allergic reactions
-
Rare: elevated liver enzymes, blood count changes
Safety Advice:
-
Administer only under medical supervision
-
Not to be self-injected
-
Avoid mixing with calcium-containing solutions
-
Use cautiously in patients with kidney or liver issues
-
Complete the full course as prescribed by a doctor
-
Store in a cool, dry place, protected from light
